BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26367229)

  • 1. A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.
    Sobol U; Go A; Kliethermes S; Bufalino S; Rodriguez T; Smith S; Parthasarathy M; Stiff P
    Bone Marrow Transplant; 2015 Dec; 50(12):1519-25. PubMed ID: 26367229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
    van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
    Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants.
    Page KM; Zhang L; Mendizabal A; Wease S; Carter S; Gentry T; Balber AE; Kurtzberg J
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1362-74. PubMed ID: 21277377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of post-thaw infused cell dose for predicting engraftment after unrelated cord blood transplantation].
    Wu JY; Liao C; Chen JS; Xu ZP; Li Y; Sun X; Wu SQ; Tang XW; Lu Y; Xie GE
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):754-8. PubMed ID: 21729565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.
    Hussein E; DeFor T; Wagner JE; Sumstad D; Brunstein CG; McKenna DH
    Transfusion; 2020 Jan; 60(1):144-154. PubMed ID: 31756003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Thaw Viable CD45+ Cells and Clonogenic Efficiency are Associated with Better Engraftment and Outcomes after Single Cord Blood Transplantation in Adult Patients with Malignant Diseases.
    Castillo N; García-Cadenas I; Barba P; Martino R; Azqueta C; Ferrà C; Canals C; Sierra J; Valcárcel D; Querol S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2167-2172. PubMed ID: 26319094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.
    Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
    Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
    Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreserved CD34
    Konuma T; Kato S; Oiwa-Monna M; Tanoue S; Ogawa M; Isobe M; Tojo A; Takahashi S
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1142-1150. PubMed ID: 28390987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.
    Le Bourgeois A; Labopin M; Guillaume T; Delaunay J; Foucher Y; Tessoulin B; Malard F; Ayari S; Peterlin P; Derenne S; Herry P; Cesbron A; Gagne K; Lodé L; Illiaquer M; Imbert-Marcille BM; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Exp Hematol; 2014 Nov; 42(11):945-54. PubMed ID: 25072620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of HLA matching on outcome of single unit unrelated cord blood transplantation: a retrospective single center clinical analysis].
    Sun G; Sun Z; Liu H; Zheng C; Tang B; Zhu X; Song K
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):678-83. PubMed ID: 25152111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses.
    Terakura S; Azuma E; Murata M; Kumamoto T; Hirayama M; Atsuta Y; Kodera Y; Yazaki M; Naoe T; Kato K
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):822-30. PubMed ID: 17580260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
    Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignancies.
    Moscardó F; Sanz J; Carbonell F; Sanz MA; Larrea L; Montesinos P; Lorenzo I; Vera B; Boluda B; Salazar C; Cañigral C; Planelles D; Jarque I; Solves P; Martín G; López F; de la Rubia J; Martínez J; Carpio N; Martínez-Cuadrón D; Puig N; Montoro JA; Roig R; Sanz GF
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1744-50. PubMed ID: 25008329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of double units unrelated cord blood transplantation in adult patients with hematological malignancies].
    Yin Y; Ren HY; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Wang MJ; Wang LH; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):73-7. PubMed ID: 18681304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
    Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
    Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effect of umbilical cord blood transplantation in 37 pediatric patients with hematologic malignancies: a single-center experience].
    Luan Z; Tang XF; Wu NH; Xu SX; Zhang B; Wang K; Du H
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):714-9. PubMed ID: 25008879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
    Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
    Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.
    Barker JN; Weisdorf DJ; DeFor TE; Blazar BR; McGlave PB; Miller JS; Verfaillie CM; Wagner JE
    Blood; 2005 Feb; 105(3):1343-7. PubMed ID: 15466923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.